MarketFriction

Advanced Enzyme Technologies Ltd

NSE ADVENZYMES · BSE 540025 · Biotechnology
₹274.25 -2.61%
NSE close2026-10-01
52 week range251.95 - 419.00
Market cap₹3,152 Cr.
P/E20.0
Microcap 250 Price band 20% Delivery 54.0%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales158161158155146169167186185172203190
Expenses107107102103104114122129124123140139
Operating Profit515455514255465660496351
OPM %32%33%35%33%29%33%27%30%33%29%31%27%
Other Income614-67108991020713
Interest111111111111
Depreciation999999101010101010
Profit before tax485940494253435560586054
Tax %27%28%25%28%21%27%38%26%25%26%24%28%
Net Profit354230353339274045434539
EPS in Rs3.083.742.533.052.943.372.373.573.873.803.843.31
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales293329391420444502529541624637746750
Expenses155177226236241269327382418441515526
Operating Profit138152165184203232203158206196230224
OPM %47%46%42%44%46%46%38%29%33%31%31%30%
Other Income-33156962121334650
Interest849543334542
Depreciation91318212628353535374040
Profit before tax118137139162179210171140188187233231
Tax %35%32%33%28%26%28%28%26%27%28%25%
Net Profit779394116133151124104137134174172
EPS in Rs6.978.208.079.9511.5813.0910.709.4511.9211.7215.0714.82
Dividend Payout %3%5%6%6%5%7%9%11%43%44%36%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth10%8%11%12%
Compounded Profit Growth7%1%12%15%
Stock Price CAGR-2%-6%-4%-12%
Return on Equity13%10%10%10%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital222222222222222222222222
Reserves1882564425376578179481,0661,2131,3021,3981,610
Borrowings11510154673528233534473932
Other Liabilities92716510291104153137142150151170
Total Liabilities4174505837278059711,1461,2601,4111,5211,6111,834
Fixed Assets287285421491495563601619649650679692
CWIP578111010101522412251
Investments0000111124121102360403480584
Other Assets125158153226188275413524380427430507
Total Assets4174505837278059711,1461,2601,4111,5211,6111,834
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity5493107116129141163122140141142157
Cash from Investing Activity-15-10-60-60-124-43-272-286-65-89-72
Cash from Financing Activity-36-63-65-2-43-39-26-48-26-59-73-70
Net Cash Flow221-1854-386010975-17117-2015
Free Cash Flow428897105116901439510294108105
CFO/OP88%88%105%97%70%94%94%87%112%93%103%96%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days615255555161636168586671
Inventory Days403358352339363361346402343375378335
Days Payable896857784643566067404776
Cash Conversion Cycle374342351315369379353404344393397331
Working Capital Days-4337647729094116109102112116
ROCE %25%36%31%25%24%22%22%16%12%15%13%14%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters45.92%43.62%43.50%43.02%42.95%42.92%43.08%43.08%43.08%43.04%43.26%43.25%
FIIs22.27%22.54%23.01%12.03%12.63%12.57%11.90%23.45%25.41%25.85%25.50%26.70%
DIIs6.49%6.98%7.56%8.08%8.02%8.17%8.19%8.45%6.41%5.51%5.41%4.77%
Public25.34%26.88%25.95%36.87%36.40%36.31%36.82%25.00%25.09%25.62%25.85%25.28%
No. of Shareholders72,64273,03468,64065,22266,75867,35165,32267,58969,63768,05166,19363,599

Fundamentals

Market Cap₹ 3,152 Cr.
Current Price₹ 282
Stock P/E20.0
Book Value₹ 146
ROCE14.0 %
ROE10.2 %
Dividend Yield1.90 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)12%
Compounded Profit Growth (TTM)15%
Consolidated figures.
Valuation
Market capRs 3,070 Cr
Enterprise valueRs 2,986 Cr
P/E (TTM)18.50x
Price to book1.88x
Price to sales4.09x
EV / EBITDA10.90x
EV / EBIT12.78x
EV / sales3.98x
Price to cash flow19.58x
Earnings yield5.40%
Dividend yield1.95%
P/E, 3-year average23.34x
P/B, 3-year average2.30x
P/E, 5-year average24.19x
P/B, 5-year average2.38x
Profitability
Operating margin (excl. other income)30.88%
Operating margin (incl. other income)37.06%
EBITDA margin36.55%
Pre-tax margin30.84%
Net profit margin22.13%
Net margin, latest quarter19.54%
ROE11.05%
ROCE15.13%
ROA9.79%
ROE, 3-year average10.34%
ROCE, 3-year average14.41%
ROA, 3-year average9.09%
ROE, 5-year average10.35%
ROCE, 5-year average14.34%
ROA, 5-year average9.02%
ROIC (approx.)11.27%
Tax rate25.34%
Other income / net worth2.82%
Growth
Sales growth (latest year)17.09%
Profit growth (latest year)28.68%
Sales CAGR, 3 years11.32%
Sales CAGR, 5 years8.24%
Profit CAGR, 3 years16.89%
Profit CAGR, 5 years2.91%
Sales growth QoQ-6.68%
Profit growth QoQ-13.66%
Sales growth YoY (latest quarter)2.09%
Profit growth YoY (latest quarter)-7.11%
Per share
EPS (TTM)Rs 14.82
EPS (latest year)Rs 15.07
EPS (latest quarter)Rs 3.31
EPS, 3-year averageRs 12.90
EPS, 5-year averageRs 11.77
Book value per shareRs 145.81
Sales per shareRs 66.98
Cash flow per shareRs 14.01
Free cash flow per shareRs 9.38
Dividend per share (latest year)Rs 5.35
Dividend per share, 3-year averageRs 5.22
Dividend per share, 5-year averageRs 3.53
Dividends
Dividend payout35.50%
Dividend payout, 3-year average40.89%
Dividend payout, 5-year average28.52%
Efficiency
Asset turnover0.41x
Fixed asset turnover1.08x
Inventory turnover1.53x
Inventory days238 days
Debtor days71 days
Debtors turnover5.14x
Creditor days76 days
Cash conversion cycle331 days
Working capital days116 days
Leverage
Total debtRs 32 Cr
Cash and bankRs 116 Cr
Net debtRs -84 Cr
Debt to equity0.02x
Net debt / EBITDA-0.31x
Interest coverage95.74x
Current ratio (filing 2026-03-31)9.78x
Quick ratio (filing 2026-03-31)8.12x
Trade payables (filing 2026-03-31)Rs 40 Cr
Owners' fund to total sources88.99%
Debt to assets1.75%
Cash flow
Cash from Operating Activity (latest year)Rs 157 Cr
Cash from Investing Activity (latest year)Rs -72 Cr
Cash from Financing Activity (latest year)Rs -70 Cr
Net Cash Flow (latest year)Rs 15 Cr
Free cash flow (latest year)Rs 105 Cr
FCFE (approx.: FCF + change in debt)Rs 98 Cr
Cash from ops / profit, 5 years1.04x
Sales to cash flow4.76x
Statement figures
Net sales (TTM)Rs 750 Cr
Net sales (latest year)Rs 746 Cr
Sales (latest quarter)Rs 190 Cr
Operating profit excl. other income (latest year)Rs 230 Cr
Operating profit (latest quarter)Rs 51 Cr
Other income (TTM)Rs 50 Cr
EBITDA (TTM)Rs 274 Cr
PBDT (TTM)Rs 272 Cr
Profit before tax (TTM)Rs 231 Cr
Tax (latest year)Rs 59 Cr
Net profit (TTM)Rs 166 Cr
Net profit (latest year)Rs 169 Cr
Net profit (latest quarter)Rs 37 Cr
Depreciation (TTM)Rs 40 Cr
Depreciation (latest quarter)Rs 10 Cr
Interest (TTM)Rs 2 Cr
Cost of goods sold (latest year)Rs 272 Cr
Total expenditure (latest year)Rs 515 Cr
Total income (latest year)Rs 792 Cr
Share capitalRs 22 Cr
ReservesRs 1,610 Cr
Shareholders' fundsRs 1,632 Cr
Total assetsRs 1,834 Cr
Net blockRs 692 Cr
Capital work in progressRs 51 Cr
InvestmentsRs 584 Cr
ReceivablesRs 145 Cr
InventoryRs 177 Cr
Other liabilitiesRs 170 Cr
Shares outstanding (crore)11.19
Ownership
Promoter holding43.25% (+0.17 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 18.5 is at the 12th percentile of its own 9.4-year range (median 26.1, low 14.4, high 42.2).
P/B 1.88 is the lowest in 9.4 years (median 3.07).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodADVENZYMESNifty 50Difference
1 week-6.3%-2.8% -3.5 pts
1 month-7.1%-6.8% -0.4 pts
3 months-13.6%-7.6% -6.0 pts
6 months+7.4%+0.4% +7.0 pts
1 year-16.1%-9.9% -6.2 pts
2 years-47.0%-13.6% -33.4 pts
3 years-14.4%+14.2% -28.6 pts
5 years-28.6%+27.9% -56.5 pts
11 mutual fund schemes hold about ₹58 Cr. Over three months 6 bought more and 1 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
UTI MNC Fund1.13%32 +16%
ICICI Pru ESG Exclusionary Strategy Fund1.42%19 -11%
Motilal Oswal Nifty Microcap 250 Index Fund0.15%4 +3%
JioBlackRock Flexi Cap Fund0.06%2 +9%
Bank of India ELSS Tax Saver Fund0.08%1 +10%
Groww Nifty Total Market Index Fund0.01%0 +16%
Bandhan BSE Healthcare Index Fund0.09%0 +6%
Angel One Nifty Total Market Index Fund0.01%0 +1%
Mirae Asset Nifty Total Market Index Fund0.01%0 +16%
Bandhan Nifty Total Market Index Fund0.01%0 +1%
Motilal Oswal BSE 1000 Index Fund0.01%0 +1%

Red flags

F-score 7 of 8
lookAuditor change Auditor change 2026-05-09: Advanced Enzyme Technologies Limited has informed the Exchange regarding Change in Auditors of the company.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹190 Cr +2.2% vs Jun 2025. Net profit ₹39 Cr -2.5%.
Against our estimate for Jun 2026: sales -8.5%, profit -19.2% miss. Our estimate for Sep 2026: sales Rs 207 Cr, profit Rs 48 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Anthem Biosciences Ltd48,99682.630.4 %
CCME Global Ltd208-2.92 %
Vivo Bio Tech Ltd367.74 %
Shree Ganesh Biotech India Ltd191.31 %
Genomic Valley Biotech Ltd98861.02 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-24Dividend - Rs 1.35 Per Share
2025-07-23Dividend - Rs 1.20 Per Share
2025-05-16Interim Dividend - Rs 4 Per Share
2024-07-18Dividend - Re 1.1 Per Share
2024-05-17Interim Dividend - Rs 4 Per Share
2023-08-04Dividend - Re 1 Per Share
2023-05-19Interim Dividend - Rs 4 Per Share
2022-08-11Dividend - Re 1 Per Share
2021-08-31 Dividend - Rs 0.90 Per Share
2020-07-09 Annual General Meeting/Dividend - Rs 0.60 Per Share
2019-08-01 Annual General Meeting/Dividend - Rs 0.60 Per Share
2018-09-06 Annual General Meeting/Dividend Re 0.50 Per Share
2017-09-04 Annual General Meeting/Dividend - Re 0.40 Per Share(Book Closure Dates Revised)
2017-05-25 Face Value Split From Rs 10/- Per Share To Rs 2/- Per Share0.2000
2016-09-08 Annual General Meeting
DateTypeWhat it says
2026-09-29UpdatesIntimation of receipt of revised request from a promoter group member for reclassification from Promoter Group category to Public category shareholder...
2026-09-17General UpdatesIntimation of receipt of revised request from a few promoter group members for reclassification from Promoter Group category to Public category sh...
2026-09-08UpdatesExtinguishment of Equity Shares.
2026-09-05General UpdatesIntimation of receipt of request from a few promoter group members for reclassification from Promoter Group category to Public category shareholde...
2026-08-18Concall / analyst meetTranscript
2026-08-13General UpdatesGeneral Updates
2026-08-12Concall / analyst meetLink of Recording
2026-08-11BuybackAdvanced Enzyme Technologies Limited has submitted the Exchange the Board Resolution of Buyback
2026-08-11Public Announcement - BuybacPublic Announcement - Buyback of Shares
2026-08-08Investor PresentationInvestor Presentation
2026-08-08Press ReleaseA press release dated August 08, 2026, titled "Quarterly Earnings Release".
2026-08-08AcquisitionAcquisition
2026-08-08Board meeting outcomeOutcome of Board Meeting held on August 08, 2026.
2026-08-08Board meeting outcomeAdvanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-04Concall / analyst meetSchedule of meet
2026-08-01General UpdatesGeneral Updates
2026-08-01Shareholder meetingVoting results.
2026-07-31Shareholder meetingProceedings of Annual General Meeting held on July 31, 2026
2026-07-08General UpdatesCopy of letter sent to those shareholders who have not registered their e-mail addresses with the Company/Registrar & Share Transfer Agent/Depositorie...
2026-07-08General UpdatesBusiness Responsibility and Sustainability Report for the Financial Year 2025-26.
2026-07-08Shareholder meetingNotice of Annual General Meeting to be held on July 31, 2026
2026-07-03General UpdatesThe date of the 37th Annual general Meeting of the Company.
2026-07-03Record DateRecord date for the purpose of Dividend is 24-Jul-2026.
2026-06-12Disclosure under SEBI TakeovChandrakumar Laxminarayan Rathi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi...
2026-06-11Director changeChange in Director(s) of the company.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Advanced Enzyme Technologies Ltd?

Advanced Enzyme Technologies Ltd (ADVENZYMES) has a market capitalisation of Rs 3,152 Cr. at the 2026-10-01 close.

What is the P/E ratio of Advanced Enzyme Technologies Ltd?

Advanced Enzyme Technologies Ltd trades at a P/E of 20.0 on trailing twelve-month profit, at the 2026-10-01 close.

What were Advanced Enzyme Technologies Ltd's latest quarterly results?

In the Jun 2026 quarter, Advanced Enzyme Technologies Ltd sales was Rs 190 Cr (+2.2% vs Jun 2025) and net profit was Rs 39 Cr.

What is the 52-week high and low of Advanced Enzyme Technologies Ltd?

The 52-week high is Rs 419.00 and the 52-week low is Rs 251.95.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03